Sandbox vidit: Difference between revisions
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
{{familytree | | | |!| | | | | | | |!| | | | | | | | }} | {{familytree | | | |!| | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | C01 | | | | | | C02 | | | | | | |C01=<div style="float: left; text-align: left; width:28em; padding:1em ">❑ Look for the presence of any of these: <br> | {{familytree | | | C01 | | | | | | C02 | | | | | | |C01=<div style="float: left; text-align: left; width:28em; padding:1em ">❑ Look for the presence of any of these: <br> | ||
:❑ Chronic heart failure | :❑ [[Chronic heart failure]] | ||
:❑ Hypotension | :❑ [[Hypotension]] | ||
:❑ Acute myocardial infarction <br> ❑ If present, treat as shown in the table below: | :❑ [[Acute myocardial infarction]] <br> | ||
❑ If present, treat as shown in the table below: | |||
<table class="wikitable"> | <table class="wikitable"> | ||
<tr><td>▸ '''''Conversion'''''</td><td> ▸ '''''DC cardioversion ([[ACC AHA guidelines classification scheme|class I, level of evidence C]])'''''</td></tr> | <tr><td>▸ '''''Conversion'''''</td><td> ▸ '''''DC cardioversion ([[ACC AHA guidelines classification scheme|class I, level of evidence C]])'''''</td></tr> | ||
<tr><td>▸ '''''Rate control'''''</td><td>▸ '''''[[Beta blockers]] ([[ACC AHA guidelines classification scheme|class IIa, level of evidence C]])'''''<br> or <br>▸ '''''[[Verapamil]] or [[diltiazem]] ([[ACC AHA guidelines classification scheme|class IIa, level of evidence C]])'''''<br> or <br>▸ '''''[[Digitalis]] ([[ACC AHA guidelines classification scheme|class IIb, level of evidence C]])'''''<br> or <br>▸ '''''[[Amiodarone]] ([[ACC AHA guidelines classification scheme|class IIb, level of evidence C]])'''''</td></tr> | <tr><td>▸ '''''Rate control'''''</td><td>▸ '''''[[Beta blockers]] ([[ACC AHA guidelines classification scheme|class IIa, level of evidence C]])'''''<br> or <br>▸ '''''[[Verapamil]] or [[diltiazem]] ([[ACC AHA guidelines classification scheme|class IIa, level of evidence C]])'''''<br> or <br>▸ '''''[[Digitalis]] ([[ACC AHA guidelines classification scheme|class IIb, level of evidence C]])'''''<br> or <br>▸ '''''[[Amiodarone]] ([[ACC AHA guidelines classification scheme|class IIb, level of evidence C]])'''''</td></tr> | ||
</table></div>|C02=<div style="float: left; text-align: left; width:28em;padding:1em "> ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours <br> | </table></div>|C02=<div style="float: left; text-align: left; width:28em;padding:1em "> ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours <br> ❑ Administer rate control therapy as shown in table below: | ||
<table class="wikitable"> | <table class="wikitable"> |
Revision as of 15:23, 12 March 2014
Therapeutic Approach
Shown below is an algorithm summarizing the therapeutic approach to atrial flutter.[1]
Atrial flutter | |||||||||||||||||||||||||||||||||||||||||||||||
Unstable | Stable | ||||||||||||||||||||||||||||||||||||||||||||||
❑ Look for the presence of any of these: ❑ If present, treat as shown in the table below:
| ❑ Administer anticoagulation therapy based on the risk of stroke, if total duration of flutter > 48 hours ❑ Administer rate control therapy as shown in table below:
| ||||||||||||||||||||||||||||||||||||||||||||||
❑ Attempt conversion as shown in table below:
| |||||||||||||||||||||||||||||||||||||||||||||||
❑ Assess need for therapy to prevent recurrence | |||||||||||||||||||||||||||||||||||||||||||||||
❑ Administer antiarrythmic therapy to prevent recurrences as shown below:
❑ Consider catheter ablation if antiarrhythmic therapy fails | |||||||||||||||||||||||||||||||||||||||||||||||
- ↑ "ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary". Retrieved 15 August 2013.